36.8kg/m2), and lower hemoglobin A1c (HbA1c
It has undergone clinical studies and was found to increase blood glutathione levels while supporting the immune system
It is compounded and dispensed by licensed pharmacies following a personalized telehealth consultation with a certified medical provider
In initial preclinical studies, orforglipron has been shown to stimulate insulin secretion and reduce food consumption in non-human primates, and it is fully efficacious at lowering hyperglycemia in mice expressing the human GLP-1R but inactive in GLP-1R knockout animals
AOD 9604 stands for Advanced Obesity Drug 9604
We maintain long-term relationships with proven manufacturers who follow Good Manufacturing Practices (GMP), with periodic third-party testing to verify consistency, purity, and proper molecular weight confirmation